Compare ADM & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADM | IQV |
|---|---|---|
| Founded | 1902 | 1982 |
| Country | United States | United States |
| Employees | N/A | 93000 |
| Industry | Packaged Foods | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.4B | 28.6B |
| IPO Year | 2008 | 2013 |
| Metric | ADM | IQV |
|---|---|---|
| Price | $71.41 | $171.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 16 |
| Target Price | $64.00 | ★ $230.56 |
| AVG Volume (30 Days) | ★ 3.6M | 1.2M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.88% | N/A |
| EPS Growth | N/A | ★ 4.67 |
| EPS | 2.23 | ★ 7.84 |
| Revenue | ★ $80,269,000,000.00 | $9,739,000,000.00 |
| Revenue This Year | $5.04 | $6.77 |
| Revenue Next Year | $2.74 | $5.87 |
| P/E Ratio | $32.35 | ★ $21.79 |
| Revenue Growth | N/A | ★ 41.60 |
| 52 Week Low | $43.19 | $134.65 |
| 52 Week High | $74.19 | $247.05 |
| Indicator | ADM | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 53.53 | 50.68 |
| Support Level | $57.63 | $159.42 |
| Resistance Level | $73.96 | $193.26 |
| Average True Range (ATR) | 2.44 | 6.17 |
| MACD | 0.01 | 1.66 |
| Stochastic Oscillator | 72.15 | 63.81 |
Archer-Daniels-Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. The company is also one of the largest grain merchandisers through its extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients and is a large producer of corn-based sweeteners, starches, and ethanol.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.